CoChat

The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis

Open access
Allden, Sarah J., Ogger, Patricia P., Ghai, Poonam, McErlean, Peter, Hewitt, Richard, Toshner, Richard, Walker, Simone A., Saunders, Peter, Kingston, Shaun, Molyneaux, Philip L., Maher, Toby M., Lloyd, Clare M., Byrne, Adam J. · 2019 · American Journal of Respiratory and Critical Care Medicine
Cited by 111

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Abstract Rationale Idiopathic pulmonary fibrosis (IPF) is a devastating progressive disease with limited therapeutic options. Airway macrophages (AMs) are key components of the defense of the airways and are implicated in the pathogenesis of IPF. Alterations in iron metabolism have been described during fibrotic lung disease and in murine models of lung fibrosis. However, the role of transferrin receptor 1 (CD71)-expressing AMs in IPF is not known. Objectives To assess the role of CD71-expressing AMs in the IPF lung. Methods We used multiparametric flow cytometry, gene expression analysis, and phagocytosis/transferrin uptake assays to delineate the role of AMs expressing or lacking CD71 in the BAL of patients with IPF and of healthy control subjects. Measurements and Main Results There was a distinct increase in proportions of AMs lacking CD71 in patients with IPF compared with healthy control subjects. Concentrations of BAL transferrin were enhanced in IPF-BAL, and furthermore, CD71− AMs had an impaired ability to sequester transferrin. CD71+ and CD71− AMs were phenotypically, functionally, and transcriptionally distinct, with CD71− AMs characterized by reduced expression of markers of macrophage maturity, impaired phagocytosis, and enhanced expression of profibrotic genes. Importantly, proportions of AMs lacking CD71 were independently associated with worse survival, underlining the importance of this population in IPF and as a potential therapeutic target. Conclusions Taken together, these data highlight how CD71 delineates AM subsets that play distinct roles in IPF and furthermore show that CD71− AMs may be an important pathogenic component of fibrotic lung disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201809-1775oc

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 111

Metadata

Authors
Allden, S. J., Ogger, P. P., Ghai, P., McErlean, P., Hewitt, R., Toshner, R., Walker, S. A., Saunders, P., Kingston, S., Molyneaux, P. L., Maher, T. M., Lloyd, C. M., & Byrne, A. J.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2019-07-15
Volume
200
Issue
2
Pages
209-219
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2942690674
Cited by
111
References
8
FWCI
10.54
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201809-1775oc
The paper
Allden, S. J., Ogger, P. P., Ghai, P., McErlean, P., Hewitt, R., Toshner, R., Walker, S. A., Saunders, P., Kingston, S., Molyneaux, P. L., Maher, T. M., Lloyd, C. M., & Byrne, A. J. (2019). The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201809-1775oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.